Keyphrases
Retinal pigment Epithelium
100%
Thrombin
100%
Profibrotic
100%
Vitreoretinal Disorders
100%
Factor Xa
100%
Vitreoretinal
75%
Growth Factors
75%
Chemokines
50%
Age-related Macular Degeneration
50%
Proliferative Vitreoretinopathy
50%
Proliferative Diabetic Retinopathy
50%
Blood-retinal Barrier
50%
Barrier Integrity
50%
Nuclear factor-κB
50%
Inflammatory Fibrosis
50%
Inflammation
25%
Blindness
25%
Interleukin-8
25%
Interleukin-6
25%
Platelet-derived Growth factor-BB (PDGF-BB)
25%
ARPE-19 Cells
25%
Granulocyte Colony-stimulating Factor (G-CSF)
25%
Cytokine Factors
25%
Quantitative PCR
25%
Fibrosis
25%
Signaling Cascades
25%
Coagulation Factors
25%
Neovascularization
25%
Targeted Treatment
25%
PDGF-AA
25%
Protease-activated Receptor 1 (PAR1)
25%
Fibrin Deposition
25%
Vitreoretinal Diseases
25%
1-factor
25%
Tissue Inhibitor of metalloproteinase-1 (TIMP-1)
25%
MCP-3
25%
Glass Slide
25%
Specific Inhibitor
25%
Pathophysiological Processes
25%
Causes of Visual Impairment
25%
Pathobiology
25%
Simultaneous Detection
25%
Medicine and Dentistry
Disease
100%
Thrombin
100%
Visual Pigment
100%
Epithelial Cell
100%
Prothrombinase
100%
Mediator
100%
Proliferative Vitreoretinopathy
75%
Growth Factor
75%
Fibrosis
75%
Cytokine
75%
Chemokine
50%
Platelet Derived Growth Factor
50%
Age Related Macular Degeneration
50%
Immunoglobulin Enhancer Binding Protein
50%
Proliferative Diabetic Retinopathy
50%
Blood-Retinal Barrier
50%
Amaurosis
25%
Visual Impairment
25%
Granulocyte Macrophage Colony Stimulating Factor
25%
Real-Time Polymerase Chain Reaction
25%
Interleukin-6
25%
Enzyme Linked Immunosorbent Assay
25%
Fibrin Deposition
25%
Proteinase Activated Receptor 1
25%
Blood Clotting Factor
25%
Metalloprotease Inhibitor
25%
ARPE-19 Cell Line
25%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Visual Pigment
100%
Thrombin
100%
Blood Clotting Factor 10a
100%
Cytokine
75%
Inflammation
75%
Growth Factor
75%
Vitreoretinopathy
75%
Fibrosis
75%
Age Related Macular Degeneration
50%
Chemokine
50%
Platelet Derived Growth Factor
50%
Proliferative Diabetic Retinopathy
50%
Immunoglobulin Enhancer Binding Protein
50%
Granulocyte Macrophage Colony Stimulating Factor
25%
Blood Clotting Factor
25%
Visual Impairment
25%
Neovascularization (Pathology)
25%
Enzyme-Linked Immunosorbent Assay
25%
Tissue Inhibitor of Metalloproteinase
25%
Proteinase Activated Receptor 1
25%